Paper42007444
APL-like subset within NPM1-mutated AML: A distinct immunophenotype correlating with early vascular complications.
Mannelli F and 32 others. Hemasphere, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. APL-like subset within NPM1-mutated AML: A distinct immunophenotype correlating with early vascular complications. Papers, record 42007444. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42007444
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- APL-like subset within NPM1-mutated AML: A distinct immunophenotype correlating with early vascular complications.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33047878 | Exploring the components of bleeding outcomes in transfusion trials for patients with hematologic malignancy. | Transfusion | 2021 | https://conductscience.org/library/papers/33047878 | PubMed |
| 2 | 25528069 | Thrombotic events in acute promyelocytic leukemia. | Thromb Res | 2015 | https://conductscience.org/library/papers/25528069 | PubMed |
| 3 | 38831789 | Cup-like nuclei in adult B-cell acute lymphoblastic leukemia with the translocation (4;11)(q21;q23). | Leuk Res Rep | 2024 | https://conductscience.org/library/papers/38831789 | PubMed |
| 4 | 39457595 | Characteristics and Prognosis of "Acute Promyelocytic Leukemia-like" Nucleophosmin-1-Mutated Acute Myeloid Leukemia in a Retrospective Patient Cohort. | Biomedicines | 2024 | https://conductscience.org/library/papers/39457595 | PubMed |
| 5 | 35081257 | Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy. | Blood Adv | 2022 | https://conductscience.org/library/papers/35081257 | PubMed |
| 6 | 30563875 | Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD. | Blood | 2019 | https://conductscience.org/library/papers/30563875 | PubMed |
| 7 | 40409258 | Deconvoluting clonal and cellular architecture in IDH-mutant acute myeloid leukemia. | Cell Stem Cell | 2025 | https://conductscience.org/library/papers/40409258 | PubMed |
| 8 | 38387301 | The ISTH DIC-score predicts early mortality in patients with non-promyelocitic acute myeloid leukemia. | Thromb Res | 2024 | https://conductscience.org/library/papers/38387301 | PubMed |
| 9 | 31698462 | Blast phenotype and comutations in acute myeloid leukemia with mutated NPM1 influence disease biology and outcome. | Blood Adv | 2019 | https://conductscience.org/library/papers/31698462 | PubMed |
| 10 | 31851556 | Gemtuzumab Ozogamicin in NPM1-Mutated Acute Myeloid Leukemia: Early Results From the Prospective Randomized AMLSG 09-09 Phase III Study. | J Clin Oncol | 2020 | https://conductscience.org/library/papers/31851556 | PubMed |
| 11 | 36750485 | Value of the FDP/FIB ratio in predicting early severe bleeding events in patients with newly diagnosed acute promyelocytic leukemia. | Ann Hematol | 2023 | https://conductscience.org/library/papers/36750485 | PubMed |
| 12 | 30049734 | Cuplike nuclear morphology in pediatric B-cell acute lymphoblastic leukemia. | Blood | 2018 | https://conductscience.org/library/papers/30049734 | PubMed |
| 13 | 29033137 | The global problem of early deaths in acute promyelocytic leukemia: A strategy to decrease induction mortality in the most curable leukemia. | Blood Rev | 2018 | https://conductscience.org/library/papers/29033137 | PubMed |
| 14 | 35797463 | Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. | Blood | 2022 | https://conductscience.org/library/papers/35797463 | PubMed |
| 15 | 37187198 | Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09-09): a randomised, open-label, multicentre, phase 3 trial. | Lancet Haematol | 2023 | https://conductscience.org/library/papers/37187198 | PubMed |
| 16 | 39190465 | Bleeding events in patients with cancer: incidence, risk factors, and impact on prognosis in a prospective cohort study. | Blood | 2024 | https://conductscience.org/library/papers/39190465 | PubMed |
| 17 | 7459811 | Reporting results of cancer treatment. | Cancer | 1981 | https://conductscience.org/library/papers/7459811 | PubMed |
| 18 | 30803991 | Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet. | Blood | 2019 | https://conductscience.org/library/papers/30803991 | PubMed |
| 19 | 35732831 | The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. | Leukemia | 2022 | https://conductscience.org/library/papers/35732831 | PubMed |
| 20 | 27354723 | Disseminated intravascular coagulation at diagnosis is a strong predictor for thrombosis in acute myeloid leukemia. | Blood | 2016 | https://conductscience.org/library/papers/27354723 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42878784 | Thrombotic and hemorrhagic complications in NPM1-mutated AML: Association with APL-like immunophenotype and impact on early mortality. | J Thromb Thrombolysis | 2026 | https://conductscience.org/library/papers/42878784 |
Source PubMed
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FGB | 2244 | PubTator's text mining | https://conductscience.org/library/genes/2244 | NCBI Gene |
| NPM1 | 4869 | PubTator's text mining | https://conductscience.org/library/genes/4869 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42007444
GET https://conductscience.org/api/papers/v1/42007444/authors?page=2